Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
This intro points out equity indices that qualify as total return and explains how dividends affect performance reporting.
24,588 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
A Russian actor allegedly used forged ties to the Astor name to extract roughly $450 million from a Mexican billionai...
The SEC has postponed the draft innovation exemption for tokenized stocks, signaling a longer path to allowing tradin...
The Schwab U.S. Dividend Equity ETF now concentrates 41% of its assets in its top 10 holdings, a shift that could res...
Analysts issue refreshed Tuesday notes on a slate of large-cap names, signaling where investors may push for upside a...
Raising Cane’s rides a World Cup wave as fans flood social feeds with praise for the chicken and sauce. The co-CEO’s ...
Inflation can crash a party you didn’t RSVP to. Learn a practical, step-by-step approach to shield your investments f...
AppLovin is set to report Q1 2026 after the close, with traders eyeing revenue momentum, margins and AI advertising s...
A new tech challenger aims to blend space, AI, and hardware into one powerful growth engine. This article breaks down...
A robust May jobs report sent U.S. stocks lower as investors weighed inflation risks and policy paths. Barclays warns...
GameStop’s walking away from a massive pay package marks a dramatic pivot as the company uses its stock to press a bi...
Oil prices jumped as Iran declared the Strait of Hormuz closed, raising the prospect of prolonged supply disruption. ...